Neocytolysis in the Treatment of Renal Anemia With Erythropoieses

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04925661` - HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia	Phase 1
Active, not recruiting	`NCT03388385` - Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD	Phase 4
Completed	`NCT05035641` - A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients	Phase 2
Completed	`NCT02299661` - Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease	Phase 1
Active, not recruiting	`NCT05265325` - A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis	Phase 2
Completed	`NCT05864261` - Pharmacokinetics Comparison Study of JT1801 and NESP® After Single Dose Administration in Chinese Health Male Volunteers	Phase 4
Active, not recruiting	`NCT05085275` - Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease	Phase 3
Completed	`NCT02708914` - Study to Compare the Safety and Efficacy of UB-851 and Eprex®	Phase 3
Completed	`NCT02041208` - Variability of Hemoglobin Levels After Kidney Transplantation	N/A
Not yet recruiting	`NCT04775615` - Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Healthy Subjects.	Phase 1
Completed	`NCT00298441` - Efficacy of Intravenous Iron Administration in Hemodialysis Patients	Phase 4
Active, not recruiting	`NCT04408820` - Post-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia
Completed	`NCT01543477` - Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia
Active, not recruiting	`NCT05951192` - A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease	Phase 4
Completed	`NCT04454879` - Different Doses of Roxadustat Treatment for Anemia in Peritoneal Dialysis Patients	Phase 4
Recruiting	`NCT04360902` - Assessment of an Anemia Model Predictive Controller for Anemia Management in Hemodialysis Patients	N/A
Not yet recruiting	`NCT03480178` - Renal Anemia Refractory to Erythropoietin
Completed	`NCT00322413` - Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial	Phase 3
Recruiting	`NCT05970172` - A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease	Phase 3
Completed	`NCT02947438` - Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)	Phase 3

NCT number	NCT01306409
Study type	Interventional
Source	University Hospital, Basel, Switzerland
Contact
Status	Completed
Phase	Phase 4
Start date	January 2011
Completion date	October 2011

Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms